What is BIO (BIO)?

Quick Facts

  • Token name: BIO
  • Type: Native governance token of BIO Protocol
  • Sector: Decentralized Science (DeSci)
  • Blockchains: Ethereum, Solana, Base
  • Backed by: Binance Labs, Maelstrom Fund
  • Founder: Paul Kohlhaas
  • Key mechanism: Meta-governance across multiple BioDAOs

Introduction

BIO is the native governance token of BIO Protocol, a decentralized financial layer purpose-built for biotech research. The protocol connects decentralized science (DeSci) communities, funds early-stage scientific research, and enables shared ownership of intellectual property (IP) — all on-chain.

BIO Protocol describes its category as 'Science Finance' (SciFi) — a fusion of DeFi principles and DeSci goals, designed to route capital and coordination to the best scientific ideas faster than traditional pharma or academia.

History & Background

BIO Protocol emerged from the growing DeSci movement, which uses blockchain to address funding gaps in early-stage science. Traditional pharma increasingly avoids high-risk, early-stage research, leaving valuable discoveries stranded in academia.

The protocol was founded by Paul Kohlhaas and launched its BIO token in early 2025 on Ethereum and Binance. Binance Labs invested to accelerate the protocol's growth, and a $6.9 million funding round anchored by Maelstrom Fund supported the launch of Bio V2, an AI-native platform for decentralized biotech funding.

How BIO Works

BIO Protocol operates as a 'DAO of DAOs' — an umbrella layer coordinating a network of BioDAOs, each focused on a specific research area (e.g., longevity, hair loss). The protocol takes foundational stakes in these BioDAOs and manages them through shared governance.

Research IP is tokenized via IP-NFTs and IP Tokens (IPTs) — ERC-20 tokens that encode legal agreements and research data on-chain. This makes scientific discoveries easier to license, share, or monetize.

BIO Protocol also incorporates BioAgents — AI tools that help researchers generate scientific hypotheses and surface biological insights on-chain.

Tokenomics

BIO is the central governance and coordination token of the entire ecosystem. Holders can signal which BioDAOs to support, gain whitelist access to BioDAO funding rounds, vote on BIO incentive programs, and direct funding toward specific IP assets.

The protocol issues bio/acc rewards — additional BIO tokens distributed to BioDAOs that hit key milestones, aligning incentives across the network. The BIO treasury accumulates fees and yields from on-chain liquidity across BIO tokens, BioDAO tokens, IPTs, and ETH.

Circulating supply ? 2.09 billion BIO
Reserved supply ? 968.17 million BIO
VESTING
0x0d2ADB4Af57cdac02d553e7601456739857D2eF4
968.17 million BIO
Total supply ? 3.06 billion BIO
Max supply ? -- BIO
Updated 9h ago

Ecosystem & Use Cases

  • Funding: BIO token holders vote to direct capital to specific DeSci DAOs or IP assets.
  • Meta-Governance: A single BIO token grants voting influence across multiple BioDAOs simultaneously.
  • IP Tokenization: BioDAOs tokenize research data and patents for licensing and commercialization.
  • AI Research: BioAgents generate and mint scientific hypotheses on-chain.

Notable BioDAOs include VitaDAO (longevity) and HairDAO, demonstrating the protocol's real-world biotech reach.

Team, Governance & Community

BIO Protocol was founded by Paul Kohlhaas and is backed by prominent institutional investors. Governance is community-driven — BIO holders vote on IP tokenization policies, data-sharing frameworks, and allocation of IP licensing proceeds. The ecosystem is designed so that governance power scales with participation across the broader BioDAO network.

Advantages

  • Broad governance reach: One token governs multiple BioDAOs without picking a single research area.
  • IP monetization: Tokenized IP creates new funding rails for science previously locked in academia.
  • Strong backers: Binance Labs and Maelstrom Fund lend credibility and liquidity.
  • AI integration: BioAgents bring AI-driven hypothesis generation on-chain.
  • Multi-chain: Available on Ethereum, Solana, and Base for broad accessibility.

Risks & Challenges

  • Regulatory uncertainty: Tokenizing scientific IP and biotech assets sits in a legally complex space.
  • Adoption hurdles: Convincing scientists and institutions to adopt on-chain tools is a slow process.
  • Experimental sector: DeSci remains nascent and unproven at scale.
  • Execution risk: Translating on-chain governance into real-world drug development is highly complex.
  • Smart contract risk: Multi-chain deployments increase attack surface.

Long-Term Vision

BIO Protocol aims to become the foundational financial and coordination layer for all of decentralized science. By standardizing BioDAO frameworks, deepening on-chain liquidity for scientific IP, and integrating AI research tools, the protocol envisions a world where medicines can be openly and democratically developed — from hypothesis to commercialization — entirely on-chain.

Frequently Asked Questions

BIO Protocol is a decentralized financial layer for biotech research that funds and coordinates a network of BioDAOs. It enables shared ownership and monetization of scientific intellectual property on-chain.

BIO is the native governance token used to vote on which BioDAOs to fund, access whitelists for BioDAO funding rounds, and shape IP tokenization and data-sharing policies. Holders also earn bio/acc rewards for contributing to the network.

A BioDAO is a decentralized autonomous organization focused on a specific biotech or scientific research area, such as longevity or hair loss. BioDAOs hold portfolios of tokenized IP assets and are coordinated through the BIO Protocol.

The BIO token is available on Ethereum, Solana, and Base. It can be traded on major centralized exchanges like Binance as well as decentralized platforms like Uniswap and Jupiter.

BIO Protocol is backed by Binance Labs and raised a $6.9 million funding round anchored by Maelstrom Fund. It was founded by Paul Kohlhaas.

IP Tokens are ERC-20 tokens that represent governance rights over scientific intellectual property, including research data and patents. They allow BioDAOs to license, share, and commercialize discoveries on-chain.

BioAgents are AI-driven tools within the BIO Protocol ecosystem that help researchers generate scientific hypotheses and surface biological insights, with outputs minted directly on-chain.

Science Finance, or SciFi, is a term coined by BIO Protocol to describe the fusion of DeFi mechanics with DeSci goals. It aims to apply on-chain liquidity, tokenization, and governance to accelerate scientific research funding.